Physician Wealth Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History

Physician Wealth Advisors’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.41K	Hold	83	–	–	﹤0.01%	1672
2026 Q1	$1.23K	Hold	83	–	–	﹤0.01%	1561
2025 Q4	$1.32K	Hold	83	–	–	﹤0.01%	1477
2025 Q3	$918	Sell	83 -871	-91%	-$9.51K	﹤0.01%	1631
2025 Q2	$8.08K	Buy	954 +83	+10%	+$665	﹤0.01%	683
2025 Q1	$7K	Hold	871	–	–	﹤0.01%	676
2024 Q4	$7.82K	Buy	+871	New	+$7.11K	﹤0.01%	667

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Physician Wealth Advisors's AUPH Position: Q2 2026 in Review

Physician Wealth Advisors held its Aurinia Pharmaceuticals (AUPH) position steady in Q2 2026 at 83 shares worth $1.41K. The position accounts for ﹤0.01% of the portfolio, ranked #1672.

Physician Wealth Advisors first reported a position in AUPH in Q4 2024 and has held it in 7 quarters since. The position peaked at $8.08K in Q2 2025. 283 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

Physician Wealth Advisors held 83 shares of Aurinia Pharmaceuticals worth $1.41K as of Q2 2026.
Physician Wealth Advisors left its Aurinia Pharmaceuticals share count unchanged in Q2 2026.
Aurinia Pharmaceuticals made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1672 holding.
Physician Wealth Advisors first reported a position in Aurinia Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
Physician Wealth Advisors's Aurinia Pharmaceuticals position peaked at $8.08K in Q2 2025.
283 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.